Go Pro
→ Silicon Valley Insider: 'Forget AI Stocks' (From Brownstone Research) (Ad)tc pixel Free FDBK Stock Alerts

Feedback (FDBK) Competitors

Feedback logo
GBX 6.72 0.00 (0.00%)
As of 08/21/2026 11:42 AM Eastern
Compare

FDBK vs. INHC, IQAI, DVRG, SENS, and TRLS

Should you buy Feedback stock or one of its competitors? Feedback's main competitors and comparable companies include Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), and Trellus Health (TRLS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Feedback compare to Induction Healthcare Group?

Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Feedback has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Induction Healthcare Group has a beta of -0.41, meaning that its stock price is 141% less volatile than the broader market.

In the previous week, Feedback's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Induction Healthcare Group Neutral

Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -845.25%. Induction Healthcare Group's return on equity of -14.58% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Induction Healthcare Group -23.86%-14.58%-7.32%

Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.47-£10.84M-£15.74N/A
Induction Healthcare Group£12.57M0.72-£5.12M-£5.54N/A

24.8% of Feedback shares are held by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are held by institutional investors. 8.0% of Feedback shares are held by insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Induction Healthcare Group beats Feedback on 8 of the 11 factors compared between the two stocks.

How does Feedback compare to IQ-AI?

IQ-AI (LON:IQAI) and Feedback (LON:FDBK) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

IQ-AI has a net margin of -77.52% compared to Feedback's net margin of -845.25%. Feedback's return on equity of -135.17% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Feedback -845.25%-135.17%-22.99%

24.8% of Feedback shares are held by institutional investors. 66.0% of IQ-AI shares are held by company insiders. Comparatively, 8.0% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

IQ-AI has a beta of 2.25, suggesting that its share price is 125% more volatile than the broader market. Comparatively, Feedback has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market.

IQ-AI has higher earnings, but lower revenue than Feedback.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Feedback£849.62K3.47-£10.84M-£15.74N/A

In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Feedback Neutral

Summary

Feedback beats IQ-AI on 5 of the 9 factors compared between the two stocks.

How does Feedback compare to DeepVerge?

Feedback (LON:FDBK) and DeepVerge (LON:DVRG) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

DeepVerge has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.47-£10.84M-£15.74N/A
DeepVerge£12.41M0.00-£2.46M-£0.01N/A

Feedback has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, DeepVerge has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market.

In the previous week, Feedback's average media sentiment score of 0.00 equaled DeepVerge'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
DeepVerge Neutral

DeepVerge has a net margin of -19.81% compared to Feedback's net margin of -845.25%. DeepVerge's return on equity of -10.27% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
DeepVerge -19.81%-10.27%-5.56%

24.8% of Feedback shares are held by institutional investors. Comparatively, 4.2% of DeepVerge shares are held by institutional investors. 8.0% of Feedback shares are held by insiders. Comparatively, 9.5% of DeepVerge shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

DeepVerge beats Feedback on 8 of the 10 factors compared between the two stocks.

How does Feedback compare to Sensyne Health?

Sensyne Health (LON:SENS) and Feedback (LON:FDBK) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

24.8% of Feedback shares are held by institutional investors. 8.0% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Sensyne Health's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Sensyne Health Neutral
Feedback Neutral

Sensyne Health has a net margin of 0.00% compared to Feedback's net margin of -845.25%. Sensyne Health's return on equity of 0.00% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Sensyne HealthN/A N/A N/A
Feedback -845.25%-135.17%-22.99%

Sensyne Health has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensyne Health£7.81M0.00N/A-£22.10N/A
Feedback£849.62K3.47-£10.84M-£15.74N/A

Summary

Sensyne Health beats Feedback on 5 of the 8 factors compared between the two stocks.

How does Feedback compare to Trellus Health?

Feedback (LON:FDBK) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

24.8% of Feedback shares are held by institutional investors. Comparatively, 1.6% of Trellus Health shares are held by institutional investors. 8.0% of Feedback shares are held by insiders. Comparatively, 9.6% of Trellus Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Trellus Health had 1 more articles in the media than Feedback. MarketBeat recorded 1 mentions for Trellus Health and 0 mentions for Feedback. Feedback's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Trellus Health Neutral

Feedback has a net margin of -845.25% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Trellus Health -6,826.32%-49.78%-22.76%

Trellus Health has lower revenue, but higher earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.47-£10.84M-£15.74N/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, indicating that its stock price is 151% more volatile than the broader market.

Summary

Trellus Health beats Feedback on 8 of the 12 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

Export
MetricFeedbackHealthcare Technology IndustryHealthcare SectorLON Exchange
Market Cap£2.94M£1.72B£7.33B£2.90B
Dividend Yield4.56%4.69%2.54%6.17%
P/E Ratio-0.4321.43272.90367.57
Price / Sales3.4775.95624.3983,481.74
Price / Cash1.1231.6929.0327.89
Price / Book0.125.7811.257.19
Net Income-£10.84M-£18.66M£3.47B£5.89B
7 Day Performance8.39%1.73%2.33%0.42%
1 Month Performance9.71%12.77%7.72%3.03%
1 Year Performance-49.28%-17.12%25.22%22.14%

Feedback Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 6.72
flat		N/A-49.3%£2.94M£849.62KN/A24
INHC
Induction Healthcare Group
N/AGBX 9.75
flat		N/A+0.0%£9.00M£12.57MN/A74
IQAI
IQ-AI
N/AGBX 0.80
flat		N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:FDBK) was last updated on 8/24/2026 by MarketBeat.com Staff.
From Our Partners
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel